Concepedia

Richard E. Chipkin

RE

41

Publications

1.6K

Citations

23

H-Index

1975

Active since

Affiliations

Bloomfield College(Current)

Psyadon Pharmaceuticals (United States)

University of California San Diego

University of Colorado Denver

Emory University

Richard E. Chipkin is an author at Bloomfield College specializing in neuropharmacology, medicine, and pharmacology.

Top concepts

Publications per year

1975–2018

41

Publications

41

Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

Richard E. Chipkin, Louis C. Iorio, Vicki L. Coffin et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 183 citations · Full text

A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome

Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Clinical Neuropharmacology · 2014 · 101 citations

Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.

Richard E. Chipkin, Joel G. Berger, William Billard et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 93 citations

Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.

Vicki L. Coffin, Miklos B. Latranyi, Richard E. Chipkin · Journal of Pharmacology and Experimental Therapeutics · 1989 · 87 citations

Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study

Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic et al. · Movement Disorders · 2018 · 80 citations

Rows per page

1–5 of 41